BE491329A - - Google Patents
Info
- Publication number
- BE491329A BE491329A BE491329DA BE491329A BE 491329 A BE491329 A BE 491329A BE 491329D A BE491329D A BE 491329DA BE 491329 A BE491329 A BE 491329A
- Authority
- BE
- Belgium
- Prior art keywords
- solution
- represent
- heparin
- heparinic acid
- salts
- Prior art date
Links
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 17
- 229920000669 heparin Polymers 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 description 13
- 150000003839 salts Chemical class 0.000 description 9
- 229960002897 heparin Drugs 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 230000023555 blood coagulation Effects 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920001429 chelating resin Polymers 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- WMSYKJQBWJUMLL-UHFFFAOYSA-N 4-[2-(dimethylamino)-1-hydroxyethyl]phenol Chemical compound CN(C)CC(O)C1=CC=C(O)C=C1 WMSYKJQBWJUMLL-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- DZGWFCGJZKJUFP-UHFFFAOYSA-N tyramine Chemical compound NCCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-N 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
Landscapes
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE491329A true BE491329A (enrdf_load_stackoverflow) |
Family
ID=135816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE491329D BE491329A (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE491329A (enrdf_load_stackoverflow) |
-
0
- BE BE491329D patent/BE491329A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2644785A1 (fr) | Nouveaux ligands macrocycliques azotes, procede de preparation, complexes metalliques formes par ces ligands et composition de diagnostic les contenant | |
| BE491329A (enrdf_load_stackoverflow) | ||
| JP2519205B2 (ja) | 全−シス−１，３，５−トリアミノ−２，４，６−シクロヘキサントリオ−ル誘導体 | |
| EP0325537A1 (fr) | Procédé de synthèse de l'azido-3'-desoxy-3'-thymidine et analogues | |
| CH408900A (fr) | Procédé de préparation de la 3-phénoxy-propylguanidine | |
| EP0183577A1 (fr) | Dérivés du thiadiazole actifs sur le système nerveux central, procédé d'obtension et compositions pharmaceutiques les contenant | |
| BE497828A (enrdf_load_stackoverflow) | ||
| CH407147A (fr) | Procédé de préparation de composés antitumoraux | |
| BE629407A (enrdf_load_stackoverflow) | ||
| BE540293A (enrdf_load_stackoverflow) | ||
| BE503775A (enrdf_load_stackoverflow) | ||
| EP0017525B1 (fr) | Nouveaux dérivés tétrahydroalstoniques, leur préparation et leur application en tant que médicaments | |
| BE528751A (enrdf_load_stackoverflow) | ||
| BE446318A (enrdf_load_stackoverflow) | ||
| BE493897A (enrdf_load_stackoverflow) | ||
| BE486462A (enrdf_load_stackoverflow) | ||
| CH402842A (fr) | Procédé de préparation de nouveaux dérivés de l'héparine | |
| BE501332A (enrdf_load_stackoverflow) | ||
| BE528752A (enrdf_load_stackoverflow) | ||
| BE827580A (fr) | Preparation de d et l-2-amino-1-butanol | |
| BE497580A (enrdf_load_stackoverflow) | ||
| CH522580A (fr) | Procédé de préparation de sels organiques ayant un effet thérapeutique, de l'acide p-chlorophénoxy-isobutyrique | |
| BE640118A (enrdf_load_stackoverflow) | ||
| BE633559A (enrdf_load_stackoverflow) | ||
| BE461847A (enrdf_load_stackoverflow) |